University of Arkansas for Medical Sciences performs state’s first minimally invasive heart surgery

The University of Arkansas for Medical Sciences (UAMS) performed the state’s first minimally invasive procedure to treat severe tricuspid regurgitation, a life-threatening condition caused by a leaky heart valve. FDA-approved in 2024, The EVOQUE Tricuspid Valve Replacement System utilizes a catheter inserted through the groin to replace a faulty heart valve — avoiding the risks of open-heart surgery. Michael Luna, M.D., chief of the Structural Heart Program at UAMS, led the team that treated Edis Sierra, a 53-year-old patient whose condition had been misdiagnosed for years.

After undergoing surgery in 2018 to replace a different heart valve, Sierra began to experience other symptoms that led to being referred to UAMS. Luna identified her severe tricuspid valve leakage and guided her through the qualification process for the new treatment. Following the procedure, Sierra experienced a dramatic recovery — her organ function normalized and she regained the strength to enjoy everyday life again. Her journey not only highlights the importance of accurate diagnosis and patient advocacy but also marks a milestone in cardiac care for Arkansas.

LEARN MORE